Stay updated on Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error with an '403 Forbidden' page, replacing the previous study record content. This means the trial details and related information are no longer accessible on this page.
    Difference
    19%
    Check dated 2026-09-23T19:54:56.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A new revision tag was added (Revision: v3.7.0), replacing the previous Revision: v3.6.6 to indicate a version update.
    Difference
    0.0%
    Check dated 2026-09-16T21:36:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The site underwent a small frontend revision, upgrading from v3.6.5 to v3.6.6, indicating an incremental update to the interface and internal components rather than substantive changes to study details.
    Difference
    0.0%
    Check dated 2026-09-02T18:13:07.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added a line in the Study Details noting the 2015 NIH grant/contract, linking the study to NIH funding information.
    Difference
    0.0%
    Check dated 2026-08-26T19:44:28.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new revision tag, v3.6.5, was added to the page, replacing the previous v3.6.4 and signaling a small update to the page's versioning.
    Difference
    0.0%
    Check dated 2026-08-12T09:20:32.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The revision label on the page updated from v3.6.3 to v3.6.4, representing a small update to the page metadata. This change does not modify the study details or other content visible to users.
    Difference
    0.0%
    Check dated 2026-07-21T23:25:13.000Z thumbnail image

Stay in the know with updates to Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.